Umbra provided debt advisory services to Leon Capital for their majority investment into Xynteo. In addition to providing strategic financial and debt advisory, we are a co-investor in the equity alongside Leon Capital and will be a minority shareholder in the business going forward. See press release here.

This transaction builds on Umbra's capital raising credentials, following the successful exit of Noden Pharma.